Clinical Trials Logo

Clinical Trial Summary

A retrospective cohort study to explore the association between clinical pharmacists' interventions and antibiotic consumption through the use of the medical electronic reports and to identify mortality and cost savings in hospital infectious disease.


Clinical Trial Description

The role of clinical pharmacist includes : 1. a check of suitable selection and dosing of antimicrobials according to the diagnosis, type of infection, antimicrobial cultures as possible, comorbidities of patients (renal or hepatic function, etc), adverse effect, and drug interaction with other drugs. 2. Documentation of the clinical intervention, cost-saving, adverse effect,, antimicrobial culture and antimicrobial consumption on the electronic program (CPC "clinical patient care"). 3. The clinical pharmacist inspector reviews the data recorded on CPC. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05002647
Study type Observational
Source Alexandria University
Contact Amira zidane
Phone 00201024585329
Email amira.zidan2yahoo@gmail.com
Status Not yet recruiting
Phase
Start date August 15, 2021
Completion date July 1, 2022

See also
  Status Clinical Trial Phase
Completed NCT05818215 - Impact of the Qatar 2022 FIFA World Cup on PED Use and Misuse Patterns
Active, not recruiting NCT01082978 - Portable Health Files Improve Quality of Care and Health Outcomes: a Randomized Controlled Trial N/A